Clonazepam for the treatment of panic disorder.

Nardi, Antonio E; Machado, Sergio; Almada, Leonardo Ferreira; Paes, Flávia; Silva, Adriana Cardoso; Marques, Ricardo José; Amrein, Roman; Freire, Rafael C; Martin-Santos, Rocío; Cosci, Fiammeta; Hallak, Jaime E; Crippa, José A; Arias-Carrión, Oscar

Nardi, Antonio E; Machado, Sergio; Almada, Leonardo Ferreira; Paes, Flávia; Silva, Adriana Cardoso; Marques, Ricardo José; Amrein, Roman; Freire, Rafael C; Martin-Santos, Rocío; Cosci, Fiammeta; Hallak, Jaime E; Crippa, José A; Arias-Carrión, Oscar.

Affiliation

Nardi AE; Panic and Respiration Laboratory, Institute of Psychiatry, Federal University of Rio de Janeiro, National Institute for Translational Medicine (INCT-TM), Rio de Janeiro, Brazil.

Curr Drug Targets ; 14(3): 353-64, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23256724

Subject(s)

Clonazepam/therapeutic use; GABA Modulators/therapeutic use; Panic Disorder/drug therapy; Animals; Clonazepam/adverse effects; Clonazepam/pharmacokinetics; Clonazepam/pharmacology; Controlled Clinical Trials as Topic; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Panic Disorder / Clonazepam / GABA Modulators Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2013 Document type: Article Affiliation country: Brazil Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links